QLT Inc. news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

QLT 1.82 -0.02 (-1.09%)
price chart
QLT Inc. (QLTI), Aegerion Pharma (AEGR) Enter Strategic Merger Agreement
Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) and QLT Inc. (Nasdaq: QLTI) announced that they have entered into a definitive merger agreement under which Aegerion will be merged with a wholly owned indirect subsidiary of QLT.
Aegerion Pharmaceuticals' (AEGR) CEO Mary Szela on QLT Inc. Strategic ...  Seeking Alpha
Don't Miss These Three Stocks of Healthcare: Neovasc Inc (US) (NASDAQ ...  The Point Review
QLT, Inc. (QLTI) Acquires Shares of Aralez Pharmaceuticals (ARLZ), Announces ...
QLT Inc. (NASDAQ: QLTI) today announces that it has acquired 7,200,000 common shares (the “Aralez Shares”) of Aralez Pharmaceuticals Inc. (“Aralez”) for a per share price of US$6.25 and an aggregate purchase price of US$45 million.
QLT Announces Closing of Acquisition of Shares of Aralez Pharmaceuticals Inc ...  GlobeNewswire (press release)
BRIEF-Aegerion pharmaceuticals, Qlt Inc agree to strategic merger
QLT plans to change its name upon closing of proposed transaction to Novelion Therapeutics Inc. * QLT's common shares will trade on Nasdaq global select market and Toronto stock exchange.
Should QLT Inc. (QLTI) Be On Your Radar Now?
So if you are looking for a stock flying under-the-radar that is well-equipped to bounce down the road, make sure to consider QLT Inc. Solid estimate revisions and an impressive Zacks Rank suggest that better days may be ahead for QLTI and that now ...
QLT Inc. (QLTI) Rating Reiterated by RBC Capital
QLT logo QLT Inc. (NASDAQ:QLTI)'s stock had its “sector perform” rating restated by investment analysts at RBC Capital in a research note issued to investors on Friday.
QLT Inc.: QLT Announces Results of Annual General Meeting of Shareholders  The Wall Street Transcript
QLT, Inc. (QLTI) to Buy Insite Vision, Make Investment in Araleza
QLT Inc. (NASDAQ: QLTI) announced today that it has signed definitive agreements on multiple separate transformative transactions and will be returning capital to shareholders.
QLT Announces Multiple Transactions Designed to Transform the Company and ...  Business Wire (press release)
InSite Vision Terminates Deal with QLT Inc (QLTI), Enters Merger Agreement ...
InSite also announced that it has terminated its previously announced second amended and restated merger agreement with QLT Inc. (Nasdaq: QLTI) Following discussion with both Sun Pharma and QLT, and in consultation with its outside legal and financial ...
QLT Announces Termination of Merger Agreement With InSite Vision  GlobeNewswire (press release)
Insite Vision (INSV), QLT Inc. (QLTI) Enter Amended Merger Agreement; Number ...
InSite Vision Inc. (OTC: INSV) announced that InSite and QLT Inc. (NASDAQ: QLTI) entered into a revised merger agreement under which QLT will acquire InSite Vision.
QLT and InSite Vision Agree on Amended and Restated Merger Agreement  GlobeNewswire (press release)
InSite Vision and QLT Amend Merger Agreement  Business Wire (press release)
Why Auxilium Pharmaceuticals Wants QLT, Inc.
Auxilium Pharmaceuticals (NASDAQ:AUXL) shares were down a bit today on news that it is looking to merge -- in a $354 million, all-stock deal -- with Canada-based QLT (NASDAQ:QLTI). Auxilium, which is well known for its testosterone treatments (like ...
Auxilium to Buy QLT in Latest Drug Company Tax Inversion  Bloomberg
$345M deal: Auxilium merges with Canadian biotech company  Philadelphia Business Journal (blog)
Related articles »  
Broker Outlook For QLT Inc. (NASDAQ:QLTI)
05/05/2015 - QLT Inc. was upgraded to “hold” by analysts at Zacks. The share price of QLT Inc. (NASDAQ:QLTI) was down -0.72% during the last trading session, with a day high of 1.40.